Allogenic umbilical cord blood transplantation in treating patients with non-Hodgkin's lymphomas

A. V. Novitsky, M. S. Fominykh

Research output: Contribution to journalReview articlepeer-review

Abstract

Allogenic transplantation is a one of the most effective treatments in patients with oncohematological diseases. Bone marrow and peripheral stem cells is the primary graft source for transplantation, though the use of peripheral blood and umbilical cord blood grafts is increasing. Using of umbilical cord blood grafts is treatment of choice in patients with highly aggressive resistant non-Hodgkin's lymphomas in a case of no HLA matching donor exists.

Original languageEnglish
Pages (from-to)31-35
Number of pages5
JournalCellular Transplantation and Tissue Engineering
Volume6
Issue number1
StatePublished - 1 Dec 2011

Scopus subject areas

  • Surgery
  • Transplantation

Keywords

  • Non-hodgkin's lymphomas
  • Stem cells
  • Transplantation
  • Umbilical cord blood

Fingerprint

Dive into the research topics of 'Allogenic umbilical cord blood transplantation in treating patients with non-Hodgkin's lymphomas'. Together they form a unique fingerprint.

Cite this